Skip to main content
Medical information Clinical review pending

Diagnostic Testing

Immunophenotyping by Flow Cytometry Leukemia Diagnostic Panel Plasma Cell Dyscrasias Test

This test uses flow cytometry to analyze blood or bone marrow cells, helping to diagnose and classify leukemia and plasma cell disorders. It provides crucial information for accurate diagnosis and treatment planning.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
3 mL (2 mL min.) whole blood in 1 Lavender Top (EDTA) tube AND 1 Green Top (Sodium Heparin) tube OR 2 mL (1 mL min.) Bone Marrow in 1 Green Top (Sodium Heparin) tube AND Aspirate Smear.
Results
Confirm with the laboratory before booking.
Preparation
No specific patient preparation is required. Clinical history is mandatory for accurate diagnosis. Confirm with the laboratory before booking.
Test priceKSh 20,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Immunophenotyping by Flow Cytometry Leukemia Diagnostic Panel Plasma Cell Dyscrasias Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Suspected leukemia
  • ✓Suspected plasma cell disorder
  • ✓Unexplained fatigue
  • ✓Frequent infections
  • ✓Easy bruising or bleeding
  • ✓Unexplained weight loss
  • ✓Bone pain
02

In plain language

What this test helps you understand

Diagnosis and classification of leukemia and plasma cell dyscrasias.
The Immunophenotyping by Flow Cytometry Leukemia Diagnostic Panel Plasma Cell Dyscrasias Test is a diagnostic tool used to identify and classify certain blood cancers, including leukemias and plasma cell disorders. It uses advanced flow cytometry techniques to examine the characteristics of cells in your blood or bone marrow. This analysis helps doctors understand the specific type of blood disorder present.

This test measures the presence and proportions of different cell types. It specifically looks for abnormal cell populations that might indicate leukemia or plasma cell dyscrasias, allowing for precise classification of the disease.

This test is often recommended for individuals experiencing symptoms like unexplained fatigue, frequent infections, easy bruising or bleeding, unexplained weight loss, or bone pain. People with risk factors, such as a family history of blood cancers, may also be advised to consider this test.

Benefits of this test include early detection of hematological malignancies, accurate classification to guide treatment, and prompt reporting. Sample collection is typically straightforward. Your healthcare provider will interpret the results to determine the specific type of disorder and recommend appropriate next steps.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo specific patient preparation is required. Clinical history is mandatory for accurate diagnosis. Confirm with the laboratory before booking.
Sample3 mL (2 mL min.) whole blood in 1 Lavender Top (EDTA) tube AND 1 Green Top (Sodium Heparin) tube OR 2 mL (1 mL min.) Bone Marrow in 1 Green Top (Sodium Heparin) tube AND Aspirate Smear.
MethodologyFlow Cytometry
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
Results must be interpreted in conjunction with clinical findings and other laboratory tests. The test may not detect all types of hematological malignancies. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Immunophenotyping is a laboratory technique that uses antibodies to identify and classify cells based on the proteins (antigens) on their surface or inside them. In this test, it's used to analyze blood or bone marrow cells for signs of leukemia or plasma cell disorders.
The test requires either a blood sample (collected in specific tubes) or a bone marrow sample. Your doctor will advise which sample is appropriate.
Confirm with the laboratory before booking.
Blood collection involves a simple needle prick. Bone marrow collection is a more involved procedure performed by a specialist and may cause discomfort.
The results will show the types and proportions of cells present. Your doctor will interpret these findings in the context of your symptoms and medical history to make a diagnosis.
No specific preparation is usually needed for a blood draw. If a bone marrow biopsy is required, your doctor will provide specific instructions. Clinical history is mandatory for accurate diagnosis.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp